Cabozantinib-Malate
ATC L01EX07 · 4 markets · 25 records
Cabozantinib-Malate
Forms
AU 16 records · 7 strengths
- 76.044 mgtabletCABOCIP cabozantinib (as (S)-malate) 20 mg film coated tablet bottleCABOZANTINIB CIP cabozantinib (as (S)-malate) 20 mg film coated tablet bottle、CIPLA CABOZANTINIB cabozantinib (as (S)-malate) 20 mg film coated tablet bottle、CIPMETIX cabozantinib (as (S)-malate) 20 mg film coated tablet bottle
- 50.696 mgtabletCABOCIP cabozantinib (as (S)-malate) 20 mg film coated tablet bottleCABOZANTINIB CIP cabozantinib (as (S)-malate) 20 mg film coated tablet bottle、CIPLA CABOZANTINIB cabozantinib (as (S)-malate) 20 mg film coated tablet bottle、CIPMETIX cabozantinib (as (S)-malate) 20 mg film coated tablet bottle
- 25.348 mgtabletCABOCIP cabozantinib (as (S)-malate) 20 mg film coated tablet bottleCABOZANTINIB CIP cabozantinib (as (S)-malate) 20 mg film coated tablet bottle、CIPLA CABOZANTINIB cabozantinib (as (S)-malate) 20 mg film coated tablet bottle、CIPMETIX cabozantinib (as (S)-malate) 20 mg film coated tablet bottle
- 76.03 mgtabletCABOMETYX cabozantinib (as (S)-malate) 60 mg film-coated tablet bottle
- 50.69 mgtabletCABOMETYX cabozantinib (as (S)-malate) 60 mg film-coated tablet bottle
- 25.34 mgtabletCABOMETYX cabozantinib (as (S)-malate) 60 mg film-coated tablet bottle
Records without a stated strength · 1 CABOMETYX
CA 3 records · 3 strengths
SG 3 records · 3 strengths
TW 3 records · 3 strengths
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.